Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Clinical outcome of patients with Wegener's granulomatosis treated with plasma exchange.

Aasarød K, Iversen BM, Hammerstrøm J, Bostad L, Jørstad S.

Blood Purif. 2002;20(2):167-73.

PMID:
11818680
2.

Wegener's granulomatosis: clinical course in 108 patients with renal involvement.

Aasarød K, Iversen BM, Hammerstrøm J, Bostad L, Vatten L, Jørstad S.

Nephrol Dial Transplant. 2000 May;15(5):611-8. Erratum in: Nephrol Dial Transplant 2000 Dec;15(12):2069.

3.

Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.

Haubitz M, Koch KM, Brunkhorst R.

Nephrol Dial Transplant. 1998 Jul;13(7):1713-8.

4.

Predictors of survival and organ damage in Wegener's granulomatosis.

Koldingsnes W, Nossent H.

Rheumatology (Oxford). 2002 May;41(5):572-81.

5.

Long-term outcome of 37 patients with Wegener's granulomatosis with renal involvement.

Gottenberg JE, Mahr A, Pagnoux C, Cohen P, Mouthon L, Guillevin L; French Vasculitis Study Group (FVSG).

Presse Med. 2007 May;36(5 Pt 1):771-8. Epub 2007 Apr 9.

6.

Longterm outcome of Wegener's granulomatosis in patients with renal disease requiring dialysis.

Mekhail TM, Hoffman GS.

J Rheumatol. 2000 May;27(5):1237-40.

PMID:
10813293
7.
8.
9.

Crescentic glomerulonephritis in Wegener's granulomatosis: morphology, therapy, outcome.

Grotz W, Wanner C, Keller E, Böhler J, Peter HH, Rohrbach R, Schollmeyer P.

Clin Nephrol. 1991 Jun;35(6):243-51.

PMID:
1873937
10.

Combined treatment in Wegener's granulomatosis with crescentic glomerulonephritis--clinical course and long-term outcome.

Frascà GM, Zoumparidis NG, Borgnino LC, Neri L, Neri L, Vangelista A, Bonomini V.

Int J Artif Organs. 1993 Jan;16(1):11-9.

PMID:
8458666
11.

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Levy JB, Turner AN, Rees AJ, Pusey CD.

Ann Intern Med. 2001 Jun 5;134(11):1033-42.

PMID:
11388816
12.
13.

Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.

Bergesio F, Ciciani AM, Manganaro M, Palladini G, Santostefano M, Brugnano R, Di Palma AM, Gallo M, Rosati A, Tosi PL, Salvadori M; Immunopathology Group of the Italian Society of Nephrology.

Nephrol Dial Transplant. 2008 Mar;23(3):941-51. Epub 2007 Oct 19.

14.

Prognostic factors in Wegener's granulomatosis.

Briedigkeit L, Kettritz R, Göbel U, Natusch R.

Postgrad Med J. 1993 Nov;69(817):856-61.

15.

Segmental necrotizing glomerulonephritis: diagnostic, prognostic, and therapeutic significance.

Weiss MA, Crissman JD.

Am J Kidney Dis. 1985 Oct;6(4):199-211.

PMID:
2864853
16.

Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: a 12-year single-practice experience.

Villa-Forte A, Clark TM, Gomes M, Carey J, Mascha E, Karafa MT, Roberson G, Langford CA, Hoffman GS.

Medicine (Baltimore). 2007 Sep;86(5):269-77.

17.

Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.

Liu H, Peng Y, Liu F, Xiao H, Chen X, Huang A, Liu Y.

Ren Fail. 2008;30(7):685-90. doi: 10.1080/08860220802212619.

PMID:
18704816
18.

Improved outcome in Wegener's granulomatosis and microscopic polyangiitis? A retrospective analysis of 95 cases in two cohorts.

Eriksson P, Jacobsson L, Lindell A, Nilsson JA, Skogh T.

J Intern Med. 2009 Apr;265(4):496-506. doi: 10.1111/j.1365-2796.2008.02060.x. Epub 2008 Dec 23.

19.

Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis.

Aasarød K, Bostad L, Hammerstrøm J, Jørstad S, Iversen BM.

Nephrol Dial Transplant. 2001 May;16(5):953-60.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk